Multi-cancer & pre-cancer detection technology integrated into a global cancer registry. Our Lancor Scientific Platform is based on two disruptive innovations:
OMIS cancer screening device:
with sensitivity & specificity ≥ 90%
test results at point of care in less than 2 minutes
total costs of screening & data reporting $20 / test
and robust CE marked
Authenticated test results
patient centred data records
Real-time automated transmission onto a global (& national) cancer registry
incorruptible to loss, administrative errors, or medical fraud
Real patient stories - Find cancer early
Prof. Djuro Koruga and Gopal Rao discuss OMIS (Opto Magnetic Imaging Spectroscopy) Technology in the Lancor Scientific portable screening devices.
Chief Medical Officer Prof. Roland Schlesinger discusses some of the science behind what we are doing and our global cancer registry.
CEO Aamir Butt and Head of Marketing and Global Access Dr Donald de Korte discuss the impact of early cancer screening globally.